drugset / Trial / NCT02447393

Phase 1 Study of Levocetirizine

NCT02447393

Phase 1 Completed 20 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindPrevention

Summary

This is a single center, single blind, single dose, randomized, partial cross-over study to confirm bioequivalence between levocetirizine and cetirizine.

Timeline

Start
2008-03-18
Primary completion
2008-04-30
Completion
2008-04-30

Publications

  • Background Hiroko Ino, Shigeru Nohda, Shuji Miki, Kastutoshi Hara, Toshiyasu Hirama. Comparison of levocetirizine pharmacokinetics, following a single dose of levocetirizine alone or as cetirizine in Japanese healthy male volunteers . [Jpn J Clin Pharmacol Therapeut]. 2010;41(6):309.

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 10 mg Oral
Subject Levocetirizine Unknown 5 mg Oral

Indications